In the Cancer Genome Atlas Urothelial Carcinoma (TCGA-BLCA) cohort [31], high levels of B4GALNT1 (beta-1,4-N-acetyl-galactosaminyltransferase 1) expression have been strongly linked to advanced clinical stages and poor prognosis [32]. The gene discussed is B4GALNT1; the disease is cancer.